# Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

> **NCT00538031** · PHASE2 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 52 (actual)

## Conditions studied

- Fallopian Tube Cancer
- Peritoneal Cavity Cancer
- Recurrent Ovarian Epithelial Cancer

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** celecoxib

## Key facts

- **NCT ID:** NCT00538031
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12-22
- **Primary completion:** 2011-04-21
- **Final completion:** 2019-09-13
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2023-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00538031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00538031, "Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00538031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*